Article(id=1326652630463525807, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.06.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1737993600000, receivedDateStr=2025-01-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228235116, onlineDateStr=2026-11-09, pubDate=1749484800000, pubDateStr=2025-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228235116, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228235116, creator=13701087609, updateTime=1794228235116, updator=13701087609, issue=Issue{id=1326652618341987109, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='6', pageStart='529', pageEnd='636', issueExtLink='null', onlineDate='null', pubDate='1749484800000', pubDateStr='2025-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228232226, creator='13701087609', updateTime=1794273016466, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840457423860645, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840457423860646, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=541, endPage=547, ext={EN=ArticleExt(id=1326652630740349873, articleId=1326652630463525807, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=New advances in drug therapy for rheumatoid arthritis, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Rheumatoid arthritis(RA), a common chronic autoimmune disease. In addition to glucocorticoids, non-steroidal anti-inflammatory drugs, and herbal medicines, the treatment drugs for this disease also include disease -modifying anti-rheumatic drugs(DMARDs). DMARDs include traditional DMARDs, biological disease-modifying anti-rheumatic drugs (bDMARDs) and targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs). The latter two are also breakthrough therapeutic drugs for RA in recent years. This article provided a detailed introduction to bDMARDs and tsDMARDs, and briefly described other potential therapeutic drugs, to provide new ideas and directions for clinical medication.

, authors=Yingying WANG1, Shuhong JI2, Guangtao XIA3, *, authorsList=Yingying WANG, Shuhong JI, Guangtao XIA, authorCompany=null, correspAuthors=Guangtao XIA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652631088477106, articleId=1326652630463525807, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=类风湿性关节炎药物治疗新进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

类风湿性关节炎(rheumatoid arthritis,RA)是一种常见的慢性自身免疫性疾病,治疗药物除糖皮质激素、非甾体抗炎药、植物药外,还包括疾病修饰抗风湿药物(disease-modifying anti-rheumatic drugs,DMARDs)。DMARDs包括传统DMARDs、生物制剂DMARDs(biological disease-modifying anti-rheumatic drugs,bDMARDs)和靶向合成DMARDs(targeted synthetic disease-modifying anti-rheumatic drugs,tsDMARDs),后两者是近年来RA治疗的突破性进展用药。文章详细介绍bDMARDs和tsDMARDs,并简述其他潜在治疗药物,以期为临床用药提供新思路、新方向。

, authors=王营营1, 纪淑红2, 夏光涛3, *, authorsList=王营营, 纪淑红, 夏光涛, authorCompany=null, correspAuthors=夏光涛, authorNote=

王营营,主治医师,研究方向:风湿免疫疾病诊治。

, correspAuthorsNote=
夏光涛,主任医师,研究方向:风湿免疫疾病诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=MtUZgeYbIHHsC78K1uNTCg==, magXml=cnivwWtu67dLEB72XuBaIQ==, pdfUrl=null, pdf=HOSYDimXMY+mtVgfFPI0TA==, pdfFileSize=955224, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8Hq2fkvUPWE7zmjFtUjLeA==, mapNumber=null, fund=null)}, authors=[Author(id=1326652631797314494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652631906366400, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652631797314494, language=EN, stringName=Yingying WANG, firstName=Yingying, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652631977669569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652631797314494, language=CN, stringName=王营营, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.济南市市中区人民医院内科,山东 济南 250000, bio={"content":"

王营营,主治医师,研究方向:风湿免疫疾病诊治。

"}, bioImg=null, bioContent=

王营营,主治医师,研究方向:风湿免疫疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631356912563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=1., ext=[AuthorCompanyExt(id=1326652631365301172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652631465964469, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])]), Author(id=1326652632044778435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652632111887301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632044778435, language=EN, stringName=Shuhong JI, firstName=Shuhong, middleName=null, lastName=JI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652632191579078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632044778435, language=CN, stringName=纪淑红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.日照市莒县人民医院内科,山东 日照 276500, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631579210678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=2., ext=[AuthorCompanyExt(id=1326652631587599287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China), AuthorCompanyExt(id=1326652631616959416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.日照市莒县人民医院内科,山东 日照 276500)])]), Author(id=1326652632262882248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652632338379722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632262882248, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652632447431627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632262882248, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631696651193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=3., ext=[AuthorCompanyExt(id=1326652631705039802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652631713428411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])], keywords=[Keyword(id=1326652632539706316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=EN, orderNo=1, keyword=rheumatoid arthritis), Keyword(id=1326652632602620877, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=EN, orderNo=2, keyword=biological disease-modifying anti-rheumatic drug), Keyword(id=1326652632669729742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=EN, orderNo=3, keyword=targeted synthesis of disease-modifying anti-rheumatic drug), Keyword(id=1326652632728449999, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=CN, orderNo=1, keyword=类风湿性关节炎), Keyword(id=1326652632799753168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=CN, orderNo=2, keyword=生物制剂疾病修饰抗风湿药物), Keyword(id=1326652632858473425, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, language=CN, orderNo=3, keyword=靶向合成疾病修饰抗风湿药物)], refs=[Reference(id=1326652633051411411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=GBD 2021 Rheumatoid Arthritis Collaborators. Global,regional, and national burden of rheumatoid arthritis, 1990 —2020, and projections to 2050: results from the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5(10):e594-e610., articleTitle=null, refAbstract=null), Reference(id=1326652633122714580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=KAY J, FLEISCHMANN R, KEYSER C, et al. Safety and immunogenicity of etanercept in patients with rheumatoid arthritis over 10 years of treatment[J]. Arthritis Res Ther,2021, 23(1): 45., articleTitle=null, refAbstract=null), Reference(id=1326652633185629141, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI X, GUAN F, HE Y, et al. Curative effect analysis on etanercept combined with methotrexate in the treatment of rheumatoid arthritis[J]. PMB, 2024, 14(29): 5695-5698., articleTitle=null, refAbstract=null), Reference(id=1326652633252738006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=TAYLOR PC, ALETAHA D, SMOLEN JS, et al. Etanercept in rheumatoid arthritis: a review of 20 years of clinical experience[J]. Nat Rev Rheumatol, 2022, 18(3): 156-170., articleTitle=null, refAbstract=null), Reference(id=1326652633319846871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SMOLEN JS, LANDEWE RBM, BERGMAN MJ, et al.Etanercept monotherapy versus combination therapy with methotrexate in rheumatoid arthritis: a systematic review and meta-analysis of efficacy and safety[J]. Ann Rheum Dis,2021, 80(6): 734-741., articleTitle=null, refAbstract=null), Reference(id=1326652633378567128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=EMERY P, BREEDVELD FC, HALL S, et al. Comparison of etanercept monotherapy and combination therapy with methotrexate in early rheumatoid arthritis: results from the COMET study[J]. Rheumatology(Oxford), 2022, 61(3):1123-1132., articleTitle=null, refAbstract=null), Reference(id=1326652633445675993, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=BURMESTER GR, PATTEN C, KIVITZ AJ, et al. Etanercept dose reduction in patients with low disease activity: results from the PRIZE study[J]. J Rheumatol, 2021, 48(5): 689-697., articleTitle=null, refAbstract=null), Reference(id=1326652633508590554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LAUNOIS R, AVOUAC B, BERENBAUM F, et al.Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian meta analysis[J]. J Rheumatol, 2011,38(5): 835-845., articleTitle=null, refAbstract=null), Reference(id=1326652633571505115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FURST DE, SHAIKH SA, GREENWALD M, et al. Two dosing regimens of certolizumab pegol in patients with active rheumatoid arthritis[J]. Arthritis Care Res(Hoboken), 2015,67(2) : 151-160., articleTitle=null, refAbstract=null), Reference(id=1326652633634419676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=BYKERK VP, CUSH J, WINTHROP K, et al. Update on the safety profile of certolizumab pegol in rheumatoid arthritis:an integrated analysis from clinical trials[J]. Ann Rheum Dis,2015, 74(1): 96-103., articleTitle=null, refAbstract=null), Reference(id=1326652633688945629, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TAKEUCHI T, KAWANISHI M, NAKANISHI M,et al. Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 52-week result of a phase Ⅱ/Ⅲstudy(OHZORA trial)[J]. Mod Rheumatol, 2023, 33(5):883-890., articleTitle=null, refAbstract=null), Reference(id=1326652633756054494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LU X, HU R, PENG L, et al. Effificacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis[J]. Front Immunol, 2021, 12: 638444., articleTitle=null, refAbstract=null), Reference(id=1326652633818969055, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ISHIWATARI-OGATA C, KYUUMA M, OGATA H, et al. Ozoralizumab, a humanized anti-TNFα NANOBODY®compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNFα IgG[J]. Front Immunol, 2022, 13: 853008., articleTitle=null, refAbstract=null), Reference(id=1326652633877689312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=AGACHE I, ROCHA C, PEREIRA A, et al. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: a systematic review for the EAACI guidelines[J].Allergy, 2021, 76(1): 59-70., articleTitle=null, refAbstract=null), Reference(id=1326652633940603873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=FENG Y, CHEN C, SHAO A, et al. Emerging interleukin-1 receptor-associated kinase 4(IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer[J].Acta Pharmaceutica Sinica B, 2024, doi: 10.1016/j.apsb.2024.09.008., articleTitle=null, refAbstract=null), Reference(id=1326652634020295650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=GENOVESE MC, RUBBERT-ROTH A, SMOLEN JS, et al.Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure[J]. J Rheumatol, 2013, 40(6): 768-780., articleTitle=null, refAbstract=null), Reference(id=1326652634091598819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=刘昱廷, 曾令伟, 王柠柠. 托珠单抗联合塞来昔布对中重度类风湿关节炎患者炎症反应的影响研究[J]. 中国处方药,2023, 21(7): 103-106., articleTitle=null, refAbstract=null), Reference(id=1326652634162901988, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HARROLD LR, REED GW, KREMER JM, et al. The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor[J].Ann Rheum Dis, 2015, 74(2): 430-436., articleTitle=null, refAbstract=null), Reference(id=1326652634221622245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=GENOVESE MC, FLEISCHMANN R, COMBE B, et al.Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs(SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial[J]. Lancet, 2018,391(10139): 2513-2524., articleTitle=null, refAbstract=null), Reference(id=1326652634284536806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=COMBE B, KIVITZ A, TANAKA Y, et al. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase Ⅲrandomised clinical trial[J]. Ann Rheum Dis, 2021, 80(7):848-858., articleTitle=null, refAbstract=null), Reference(id=1326652634339062759, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SHARPE AH, PAUKEN KE. The diverse functions of the PD1 inhibitory pathway[J]. Nat Rev Immunol, 2018, 18(3):153-167., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326652632950748114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, awardId=ZR2021MH265, language=CN, fundingSource=山东省自然科学基金(ZR2021MH265), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326652631356912563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=1., ext=[AuthorCompanyExt(id=1326652631365301172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652631465964469, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)]), AuthorCompany(id=1326652631579210678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=2., ext=[AuthorCompanyExt(id=1326652631587599287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China), AuthorCompanyExt(id=1326652631616959416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.日照市莒县人民医院内科,山东 日照 276500)]), AuthorCompany(id=1326652631696651193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=3., ext=[AuthorCompanyExt(id=1326652631705039802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652631713428411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.06.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.06.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.06.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1749484800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
类风湿性关节炎药物治疗新进展
王营营 1 , 纪淑红 2 , 夏光涛 3, *
世界临床药物 | 医药专论 2025,46(6): 541-547
收起
收藏切换
世界临床药物 |医药专论 2025 , 46 (6) : 541 -547
类风湿性关节炎药物治疗新进展
全屏
[Author(id=1326652631797314494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652631906366400, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652631797314494, language=EN, stringName=Yingying WANG, firstName=Yingying, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652631977669569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652631797314494, language=CN, stringName=王营营, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.济南市市中区人民医院内科,山东 济南 250000, bio={"content":"

王营营,主治医师,研究方向:风湿免疫疾病诊治。

"}, bioImg=null, bioContent=

王营营,主治医师,研究方向:风湿免疫疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631356912563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=1., ext=[AuthorCompanyExt(id=1326652631365301172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652631465964469, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631356912563, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])]), Author(id=1326652632044778435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652632111887301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632044778435, language=EN, stringName=Shuhong JI, firstName=Shuhong, middleName=null, lastName=JI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652632191579078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632044778435, language=CN, stringName=纪淑红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.日照市莒县人民医院内科,山东 日照 276500, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631579210678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=2., ext=[AuthorCompanyExt(id=1326652631587599287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China), AuthorCompanyExt(id=1326652631616959416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631579210678, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.日照市莒县人民医院内科,山东 日照 276500)])]), Author(id=1326652632262882248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652632338379722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632262882248, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652632447431627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, authorId=1326652632262882248, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652631696651193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, xref=3., ext=[AuthorCompanyExt(id=1326652631705039802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652631713428411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652630463525807, companyId=1326652631696651193, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])]
王营营1, 纪淑红2, 夏光涛3, *
作者信息
  • 1.济南市市中区人民医院内科,山东 济南 250000
  • 2.日照市莒县人民医院内科,山东 日照 276500
  • 3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021
通讯作者:
夏光涛,主任医师,研究方向:风湿免疫疾病诊治。
作者简介:

王营营,主治医师,研究方向:风湿免疫疾病诊治。

New advances in drug therapy for rheumatoid arthritis
Yingying WANG1, Shuhong JI2, Guangtao XIA3, *
Affiliations
  • 1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China
  • 2.Department of Internal Medicine, Ju County People's Hospital, Rizhao City, Rizhao 276500, Shandong Province, China
  • 3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
出版时间: 2025-06-10 doi: 10.13683/j.wph.2025.06.003
文章导航
收藏切换

类风湿性关节炎(rheumatoid arthritis,RA)是一种常见的慢性自身免疫性疾病,治疗药物除糖皮质激素、非甾体抗炎药、植物药外,还包括疾病修饰抗风湿药物(disease-modifying anti-rheumatic drugs,DMARDs)。DMARDs包括传统DMARDs、生物制剂DMARDs(biological disease-modifying anti-rheumatic drugs,bDMARDs)和靶向合成DMARDs(targeted synthetic disease-modifying anti-rheumatic drugs,tsDMARDs),后两者是近年来RA治疗的突破性进展用药。文章详细介绍bDMARDs和tsDMARDs,并简述其他潜在治疗药物,以期为临床用药提供新思路、新方向。

类风湿性关节炎  /  生物制剂疾病修饰抗风湿药物  /  靶向合成疾病修饰抗风湿药物

Rheumatoid arthritis(RA), a common chronic autoimmune disease. In addition to glucocorticoids, non-steroidal anti-inflammatory drugs, and herbal medicines, the treatment drugs for this disease also include disease -modifying anti-rheumatic drugs(DMARDs). DMARDs include traditional DMARDs, biological disease-modifying anti-rheumatic drugs (bDMARDs) and targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs). The latter two are also breakthrough therapeutic drugs for RA in recent years. This article provided a detailed introduction to bDMARDs and tsDMARDs, and briefly described other potential therapeutic drugs, to provide new ideas and directions for clinical medication.

rheumatoid arthritis  /  biological disease-modifying anti-rheumatic drug  /  targeted synthesis of disease-modifying anti-rheumatic drug
王营营, 纪淑红, 夏光涛. 类风湿性关节炎药物治疗新进展. 世界临床药物, 2025 , 46 (6) : 541 -547 . DOI: 10.13683/j.wph.2025.06.003
Yingying WANG, Shuhong JI, Guangtao XIA. New advances in drug therapy for rheumatoid arthritis[J]. World Clinical Drug, 2025 , 46 (6) : 541 -547 . DOI: 10.13683/j.wph.2025.06.003
  • 山东省自然科学基金(ZR2021MH265)
参考文献 引证文献
排序方式:
[1]
GBD 2021 Rheumatoid Arthritis Collaborators. Global,regional, and national burden of rheumatoid arthritis, 1990 —2020, and projections to 2050: results from the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5(10):e594-e610.
[2]
KAY J, FLEISCHMANN R, KEYSER C, et al. Safety and immunogenicity of etanercept in patients with rheumatoid arthritis over 10 years of treatment[J]. Arthritis Res Ther,2021, 23(1): 45.
[3]
SHI X, GUAN F, HE Y, et al. Curative effect analysis on etanercept combined with methotrexate in the treatment of rheumatoid arthritis[J]. PMB, 2024, 14(29): 5695-5698.
[4]
TAYLOR PC, ALETAHA D, SMOLEN JS, et al. Etanercept in rheumatoid arthritis: a review of 20 years of clinical experience[J]. Nat Rev Rheumatol, 2022, 18(3): 156-170.
[5]
SMOLEN JS, LANDEWE RBM, BERGMAN MJ, et al.Etanercept monotherapy versus combination therapy with methotrexate in rheumatoid arthritis: a systematic review and meta-analysis of efficacy and safety[J]. Ann Rheum Dis,2021, 80(6): 734-741.
[6]
EMERY P, BREEDVELD FC, HALL S, et al. Comparison of etanercept monotherapy and combination therapy with methotrexate in early rheumatoid arthritis: results from the COMET study[J]. Rheumatology(Oxford), 2022, 61(3):1123-1132.
[7]
BURMESTER GR, PATTEN C, KIVITZ AJ, et al. Etanercept dose reduction in patients with low disease activity: results from the PRIZE study[J]. J Rheumatol, 2021, 48(5): 689-697.
[8]
LAUNOIS R, AVOUAC B, BERENBAUM F, et al.Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian meta analysis[J]. J Rheumatol, 2011,38(5): 835-845.
[9]
FURST DE, SHAIKH SA, GREENWALD M, et al. Two dosing regimens of certolizumab pegol in patients with active rheumatoid arthritis[J]. Arthritis Care Res(Hoboken), 2015,67(2) : 151-160.
[10]
BYKERK VP, CUSH J, WINTHROP K, et al. Update on the safety profile of certolizumab pegol in rheumatoid arthritis:an integrated analysis from clinical trials[J]. Ann Rheum Dis,2015, 74(1): 96-103.
[11]
TAKEUCHI T, KAWANISHI M, NAKANISHI M,et al. Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 52-week result of a phase Ⅱ/Ⅲstudy(OHZORA trial)[J]. Mod Rheumatol, 2023, 33(5):883-890.
[12]
LU X, HU R, PENG L, et al. Effificacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis[J]. Front Immunol, 2021, 12: 638444.
[13]
ISHIWATARI-OGATA C, KYUUMA M, OGATA H, et al. Ozoralizumab, a humanized anti-TNFα NANOBODY®compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNFα IgG[J]. Front Immunol, 2022, 13: 853008.
[14]
AGACHE I, ROCHA C, PEREIRA A, et al. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: a systematic review for the EAACI guidelines[J].Allergy, 2021, 76(1): 59-70.
[15]
FENG Y, CHEN C, SHAO A, et al. Emerging interleukin-1 receptor-associated kinase 4(IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer[J].Acta Pharmaceutica Sinica B, 2024, doi: 10.1016/j.apsb.2024.09.008.
[16]
GENOVESE MC, RUBBERT-ROTH A, SMOLEN JS, et al.Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure[J]. J Rheumatol, 2013, 40(6): 768-780.
[17]
刘昱廷, 曾令伟, 王柠柠. 托珠单抗联合塞来昔布对中重度类风湿关节炎患者炎症反应的影响研究[J]. 中国处方药,2023, 21(7): 103-106.
[18]
HARROLD LR, REED GW, KREMER JM, et al. The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor[J].Ann Rheum Dis, 2015, 74(2): 430-436.
[19]
GENOVESE MC, FLEISCHMANN R, COMBE B, et al.Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs(SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial[J]. Lancet, 2018,391(10139): 2513-2524.
[20]
COMBE B, KIVITZ A, TANAKA Y, et al. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase Ⅲrandomised clinical trial[J]. Ann Rheum Dis, 2021, 80(7):848-858.
[21]
SHARPE AH, PAUKEN KE. The diverse functions of the PD1 inhibitory pathway[J]. Nat Rev Immunol, 2018, 18(3):153-167.
2025年第46卷第6期
49
14
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.06.003
  • 接收时间:2025-01-28
  • 首发时间:2026-11-09
  • 出版时间:2025-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-01-28
基金
山东省自然科学基金(ZR2021MH265)
作者信息
    1.济南市市中区人民医院内科,山东 济南 250000
    2.日照市莒县人民医院内科,山东 日照 276500
    3.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021

通讯作者:

夏光涛,主任医师,研究方向:风湿免疫疾病诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏